Skip Navigation


International Immunology Advance Access originally published online on June 20, 2005
International Immunology 2005 17(7):909-919; doi:10.1093/intimm/dxh271
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/7/909    most recent
dxh271v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (51)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Baban, B.
Right arrow Articles by Mellor, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baban, B.
Right arrow Articles by Mellor, A. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2005. All rights reserved. For permissions, please e-mail: journals.permissions@oupjournals.org

A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation

Babak Baban1,*, Anna M. Hansen1,*, Phillip R. Chandler1,2, Anna Manlapat1, Adam Bingaman1,3, David J. Kahler1, David H. Munn1,4 and Andrew L. Mellor1,2

1 Immunotherapy Center and 2 Department of Medicine, 3 Department of Surgery and 4 Department of Pediatrics, Medical College of Georgia, 1120, 15th Street, Augusta, GA 30912, USA

Correspondence to: A. L. Mellor; E-mail: amellor{at}mcg.edu

By ligating CD80/CD86 (B7) molecules, the synthetic immunomodulatory reagent CTLA4-Ig (soluble synthetic CTLA4 fusion protein) induces expression of the enzyme indoleamine 2,3-dioxygenase (IDO) in some dendritic cells (DCs), which acquire potent T cell regulatory functions as a consequence. Here we show that this response occurred exclusively in a population of splenic DCs co-expressing the marker CD19. B7 ligation induced activation of the transcription factor signal transducer and activator of transcription (STAT1) in sorted CD19+, but not CD19NEG, DCs. STAT1 activation occurred even when DCs lacked receptors for type II IFN (IFN{gamma}); however, STAT1 activation and IDO up-regulation were not observed when DCs lacked receptors for type I IFN (IFN{alpha}ß). Thus, IFN{alpha}, but not IFN{gamma}, signaling was essential for STAT1 activation and IDO up-regulation in CD19+ DCs following B7 ligation. Consistent with these findings, B7 ligation also induced sorted CD19+, but not CD19NEG, DCs to express IFN{alpha}. Moreover, recombinant IFN{alpha} induced CD19+, but not CD19NEG, DCs to mediate IDO-dependent T cell suppression, showing that IFN{alpha} signaling could substitute for upstream signals from B7. These data reveal that a minor population of splenic DCs expressing the CD19 marker is uniquely responsive to B7 ligation, and that IFN{alpha}-mediated STAT1 activation is an essential intermediary signaling pathway that promotes IDO induction in these DCs. Thus, CD19+ DCs may be a target for regulatory T cells expressing surface CTLA4, and may suppress T cell responses via induction of IDO.

Keywords: CTLA4-Ig, dendritic cells, interferon, STAT1, T cell suppression

* These authors contributed equally to this study.

Transmitting editor: E. Simpson


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
T. N. Jorgensen, J. Alfaro, H. L. Enriquez, C. Jiang, W. M. Loo, S. Atencio, M. R. G. Bupp, C. M. Mailloux, T. Metzger, S. Flannery, et al.
Development of Murine Lupus Involves the Combined Genetic Contribution of the SLAM and Fc{gamma}R Intervals within the Nba2 Autoimmune Susceptibility Locus
J. Immunol., January 15, 2010; 184(2): 775 - 786.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. S. Vinay, C. H. Kim, K. H. Chang, and B. S. Kwon
PDCA Expression by B Lymphocytes Reveals Important Functional Attributes
J. Immunol., January 15, 2010; 184(2): 807 - 815.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Baban, P. R. Chandler, M. D. Sharma, J. Pihkala, P. A. Koni, D. H. Munn, and A. L. Mellor
IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells
J. Immunol., August 15, 2009; 183(4): 2475 - 2483.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. N. Scott, J. DuHadaway, E. Pigott, N. Ridge, G. C. Prendergast, A. J. Muller, and L. Mandik-Nayak
The Immunoregulatory Enzyme IDO Paradoxically Drives B Cell-Mediated Autoimmunity
J. Immunol., June 15, 2009; 182(12): 7509 - 7517.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Zeng, S. Cai, Y. Yi, Y. He, Z. Wang, G. Jiang, X. Li, and J. Du
Prevention of Spontaneous Tumor Development in a ret Transgenic Mouse Model by Ret Peptide Vaccination with Indoleamine 2,3-Dioxygenase Inhibitor 1-Methyl Tryptophan
Cancer Res., May 1, 2009; 69(9): 3963 - 3970.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. J. Muller, M. D. Sharma, P. R. Chandler, J. B. DuHadaway, M. E. Everhart, B. A. Johnson III, D. J. Kahler, J. Pihkala, A. P. Soler, D. H. Munn, et al.
Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase
PNAS, November 4, 2008; 105(44): 17073 - 17078.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Walter, C. Bonifer, and H. Tagoh
Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse Cd19 locus
Blood, September 1, 2008; 112(5): 1673 - 1682.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Orbach, J. Rachmilewitz, M. Parnas, J.-H. Huang, M. L. Tykocinski, and M. Dranitzki-Elhalel
CTLA-4 {middle dot} FasL Induces Early Apoptosis of Activated T Cells by Interfering with Anti-Apoptotic Signals
J. Immunol., December 1, 2007; 179(11): 7287 - 7294.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. John and P. J. Nelson
Dendritic Cells in the Kidney
J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2628 - 2635.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. W. Kin and V. M. Sanders
CD86 Regulates IgG1 Production via a CD19-Dependent Mechanism
J. Immunol., August 1, 2007; 179(3): 1516 - 1523.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Watanabe, M. Fujimoto, N. Ishiura, Y. Kuwano, H. Nakashima, N. Yazawa, H. Okochi, S. Sato, T. F. Tedder, and K. Tamaki
CD19 Expression in B Cells Is Important for Suppression of Contact Hypersensitivity
Am. J. Pathol., August 1, 2007; 171(2): 560 - 570.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Boasso, J.-P. Herbeuval, A. W. Hardy, S. A. Anderson, M. J. Dolan, D. Fuchs, and G. M. Shearer
HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells
Blood, April 15, 2007; 109(8): 3351 - 3359.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. Forsythe, M. D. Inman, and J. Bienenstock
Oral Treatment with Live Lactobacillus reuteri Inhibits the Allergic Airway Response in Mice
Am. J. Respir. Crit. Care Med., March 15, 2007; 175(6): 561 - 569.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D.-Y. Hou, A. J. Muller, M. D. Sharma, J. DuHadaway, T. Banerjee, M. Johnson, A. L. Mellor, G. C. Prendergast, and D. H. Munn
Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates with Antitumor Responses
Cancer Res., January 15, 2007; 67(2): 792 - 801.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. L. Mellor, B. Baban, P. R. Chandler, A. Manlapat, D. J. Kahler, and D. H. Munn
Cutting Edge: CpG Oligonucleotides Induce Splenic CD19+ Dendritic Cells to Acquire Potent Indoleamine 2,3-Dioxygenase-Dependent T Cell Regulatory Functions via IFN Type 1 Signaling
J. Immunol., November 1, 2005; 175(9): 5601 - 5605.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
F. Fallarino, C. Orabona, C. Vacca, R. Bianchi, S. Gizzi, C. Asselin-Paturel, M. C. Fioretti, G. Trinchieri, U. Grohmann, and P. Puccetti
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells
Int. Immunol., November 1, 2005; 17(11): 1429 - 1438.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.